Biogen BIIB
NASDAQ BIIB
$253.84 +12.86 (+5.34%)
At close: Oct 22, 2026 · 4:00 PM EDT

Biogen (BIIB) Accumulated Expenses (2010 - 2011)

Updated

Biogen (BIIB) posted Accumulated Expenses of $1.4 million for Q4 2011, down 97.9% from $66.4 million a year earlier.

Analysis

Biogen (BIIB) Accumulated Expenses (2010 - 2011) Analysis & Trends

  • In prior years, Biogen's Accumulated Expenses was $66.4 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Biogen 36.75 Bn 23.40 Bn 1.96 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 23.00 Mn
Dec 31, 2010 88.00 Mn
API Access

Biogen Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BIIB&period=max&api_key=YOUR_API_KEY